These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 25794492)

  • 21. Vaccination with monoclonal anti-idiotypic antibody on immunocompetent mice bearing human ovarian carcinoma.
    Qian H; Wang J; Feng J
    Chin Med J (Engl); 1997 Apr; 110(4):259-63. PubMed ID: 9594224
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Human high molecular weight melanoma-associated antigen mimicry by mouse anti-idiotypic monoclonal antibody MK2-23: enhancement of immunogenicity of anti-idiotypic monoclonal antibody MK2-23 by fusion with interleukin 2.
    Wang X; Ko EC; Peng L; Gillies SD; Ferrone S
    Cancer Res; 2005 Aug; 65(15):6976-83. PubMed ID: 16061683
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of immunological responses in patients with ovarian cancer treated with the anti-idiotype vaccine ACA125 by determination of intracellular cytokines--a preliminary report.
    Reinartz S; Boerner H; Koehler S; Von Ruecker A; Schlebusch H; Wagner U
    Hybridoma; 1999 Feb; 18(1):41-5. PubMed ID: 10211787
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Anti-idiotypic single chain mimicking CA125 linked with tuftsin provides protective immunity against ovarian cancer in mice.
    Yuan W; Xia G; Zhao C; Sui C; Ma J
    Mol Med Rep; 2012 Feb; 5(2):388-94. PubMed ID: 22020296
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunological responses to the tumor-associated antigen CA125 in patients with advanced ovarian cancer induced by the murine monoclonal anti-idiotype vaccine ACA125.
    Wagner U; Schlebusch H; Köhler S; Schmolling J; Grünn U; Krebs D
    Hybridoma; 1997 Feb; 16(1):33-40. PubMed ID: 9085126
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vitro induction of tumor-specific human lymphocyte antigen class I-restricted CD8 cytotoxic T lymphocytes by ovarian tumor antigen-pulsed autologous dendritic cells from patients with advanced ovarian cancer.
    Santin AD; Hermonat PL; Ravaggi A; Bellone S; Pecorelli S; Cannon MJ; Parham GP
    Am J Obstet Gynecol; 2000 Sep; 183(3):601-9. PubMed ID: 10992180
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Monoclonal anti-idiotype antibody 6G6.C4 fused to GM-CSF is capable of breaking tolerance to carcinoembryonic antigen (CEA) in CEA-transgenic mice.
    Schwegler C; Dorn-Beineke A; Nittka S; Stocking C; Neumaier M
    Cancer Res; 2005 Mar; 65(5):1925-33. PubMed ID: 15753392
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Anti-TAG-72 antibody B72.3--immunological and clinical effects in ovarian carcinoma.
    Schmolling J; Reinsberg J; Wagner U; Krebs D
    Hybridoma; 1997 Feb; 16(1):53-8. PubMed ID: 9085129
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Towards an idiotype vaccine against mammary tumors. Induction of an immune response to breast cancer-associated antigens by anti-idiotypic antibodies.
    Smorodinsky NI; Ghendler Y; Bakimer R; Chaitchuk S; Keydar I; Shoenfeld Y
    Eur J Immunol; 1988 Nov; 18(11):1713-8. PubMed ID: 2849550
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Activation of cellular immunity after intracavitary monoclonal antibody therapy of ovarian cancer.
    Kosmas C; Epenetos AA; Courtenay-Luck NS
    Cancer; 1994 Jun; 73(12):3000-10. PubMed ID: 8199996
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Construction and characterization of a chimeric fusion protein consisting of an anti-idiotype antibody mimicking a breast cancer-associated antigen and the cytokine GM-CSF.
    Tripathi PK; Qin H; Bhattacharya-Chatterjee M; Ceriani RL; Foon KA; Chatterjee SK
    Hybridoma; 1999 Apr; 18(2):193-202. PubMed ID: 10380019
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A therapeutic human anti-idiotypic antibody mimics CD55 in three distinct regions.
    Spendlove L; Li L; Potter V; Christiansen D; Loveland BE; Durrant LG
    Eur J Immunol; 2000 Oct; 30(10):2944-53. PubMed ID: 11069077
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Treatment of murine Lewis lung cancer with recombinant interleukin-12].
    Yin XL; Duan H; Peng ZP; Sun SL; Li SL
    Ai Zheng; 2006 Sep; 25(9):1087-91. PubMed ID: 16965647
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A new model of trispecific antibody resulting the cytotoxicity directed against tumor cells.
    Song LP; Cheng JL; Wang XB; Zhang Z; Fang M; Zhou ZY; Huang HL
    Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai); 2003 Jun; 35(6):503-10. PubMed ID: 12796809
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Induction of specific immunity to human colon carcinoma by anti-idiotypic antibodies to monoclonal antibody CO17-1A.
    Herlyn D; Ross AH; Iliopoulos D; Koprowski H
    Eur J Immunol; 1987 Nov; 17(11):1649-52. PubMed ID: 3500066
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Preparation of humanized ovarian carcinoma anti-idiotypic minibody.
    Chang X; Cui H; Feng J; Li Y; Liu B; Cao S; Cheng Y; Qian H
    Hybrid Hybridomics; 2003 Apr; 22(2):109-15. PubMed ID: 12831536
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The study of immunotherapy of ovarian carcinoma with anti-idiotypic antibody].
    Wang J; Qian H; Feng J
    Zhonghua Fu Chan Ke Za Zhi; 1996 Jun; 31(6):353-6. PubMed ID: 9206171
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Level of anti-mouse-antibody response induced by bi-specific monoclonal antibody OC/TR in ovarian-carcinoma patients is associated with longer survival.
    Miotti S; Negri DR; Valota O; Calabrese M; Bolhuis RL; Gratama JW; Colnaghi MI; Canevari S
    Int J Cancer; 1999 Feb; 84(1):62-8. PubMed ID: 9988234
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Monoclonal anti-idiotype antibody bearing the internal image of nasopharyngeal carcinoma associated antigen.
    Li G; Hu J; Zhou G; Zhu J; Sun Q
    Chin Med J (Engl); 2001 Sep; 114(9):962-6. PubMed ID: 11780392
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antitumor mechanism of recombinant murine interleukin-12 vaccine.
    Yin X; Yan X; Yang Q; Cao H; Liang H
    Cancer Biother Radiopharm; 2010 Jun; 25(3):263-8. PubMed ID: 20578831
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.